Home » Topics » Regulatory

Regulatory
RSS

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Tacrolimus ointment effective in animal model of contact dermatitis

Sep. 19, 1997

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

FDA panel recommends approval of Anesta's Actiq for cancer pain

Sep. 18, 1997

Biovail licenses diltiazem for Scandinavian market

Sep. 17, 1997

Generic version of pediatric ibuprofen receives tentative approval from FDA

Sep. 17, 1997

Thailand grants first approval for WF-10

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...